GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Ringpu Bio-Technology Co Ltd (SZSE:300119) » Definitions » Gross-Profit-to-Asset %

Tianjin Ringpu Bio-Technology Co (SZSE:300119) Gross-Profit-to-Asset % : 15.35% (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Tianjin Ringpu Bio-Technology Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Tianjin Ringpu Bio-Technology Co's annualized Gross Profit for the quarter that ended in Mar. 2024 was ¥1,018 Mil. Tianjin Ringpu Bio-Technology Co's average Total Assets over the quarter that ended in Mar. 2024 was ¥6,630 Mil. Therefore, Tianjin Ringpu Bio-Technology Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 15.35%.


Tianjin Ringpu Bio-Technology Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Tianjin Ringpu Bio-Technology Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Ringpu Bio-Technology Co Gross-Profit-to-Asset % Chart

Tianjin Ringpu Bio-Technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.10 28.97 21.68 17.12 17.59

Tianjin Ringpu Bio-Technology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.88 19.17 18.94 19.28 15.35

Competitive Comparison of Tianjin Ringpu Bio-Technology Co's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Ringpu Bio-Technology Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianjin Ringpu Bio-Technology Co's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianjin Ringpu Bio-Technology Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Tianjin Ringpu Bio-Technology Co's Gross-Profit-to-Asset % falls into.



Tianjin Ringpu Bio-Technology Co Gross-Profit-to-Asset % Calculation

Tianjin Ringpu Bio-Technology Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=1117.45/( (6106.274+6595.942)/ 2 )
=1117.45/6351.108
=17.59 %

Tianjin Ringpu Bio-Technology Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=1017.884/( (6595.942+6664.48)/ 2 )
=1017.884/6630.211
=15.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Tianjin Ringpu Bio-Technology Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Tianjin Ringpu Bio-Technology Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianjin Ringpu Bio-Technology Co (SZSE:300119) Business Description

Traded in Other Exchanges
N/A
Address
No.6, Liujing Road, Developing Zone, Tianjin, CHN, 300300
Tianjin Ringpu Bio-Technology Co Ltd is a China-based company. It is engaged in biotechnology and animal medicine, focusing on the national demand for agricultural sustainable development. The company provides products for Poultry; Swine; Pet; Aquatic; and Cattle and Sheep.

Tianjin Ringpu Bio-Technology Co (SZSE:300119) Headlines

No Headlines